TOKYO -- Stocks of midsize Japanese pharmaceutical companies have become beneficiaries of market expectations over "Suganomics," Prime Minister Yoshihide Suga's policy initiatives.
Investors started scouring the market for stocks that could ride on the momentum of the new leader's agenda even before he became prime minister.
